3 outstanding programmes bringing together Europe's key genomics
experts in Next Generation Sequencing, Single Cell Analysis, GENOME
EDITING. 80+ case studies, solution And technology presentations And 2
interactive workshops over the 2 days. 07 April 2019 - Day One -
GENOME EDITING TECHNOLOGIES AND TECHNIQUES - Drug Discovery And
Development Applications in In Vivo Therapeutics 08 April 2019 - Day
Two - Drug Discovery And Development - Target Identification and
Validation - Non-Human Models in Diagnostics And Therapeutics View
Agenda: http://bit.ly/2rLMzeL [http://bit.ly/2rLMzeL] 2020 Live
Webinar Chemically-Modified Polynucleotides for Inhibiting, Expressing
and Repairing Nucleic Acids: Then And Now Presented by Tod Woolf,
Founder And CEO, ETAGEN Pharma, Inc. Tuesday, 10 March 2020 | 03:30 PM
GMT Register: https://bit.ly/2QvO7Us [https://bit.ly/2QvO7Us]
Speakers: George Church, Professor of Genetics, Health Sciences and
Technology, Wyss Institute at Harvard University, Tod Woolf, Founder
and Chief Executive Officer, ETAGEN Pharma, Inc., Svetlana
Belyanskaya, Scientific Leader, Encoded Library Technologies,
GlaxoSmithKline, Salil Desai, Chief Executive Officer, PhenomYX, Luhan
Yang, Co-Founder and Chief Scientific Officer, eGenesis, Nadeem
Sarwar, Founder And President, Eisai Center for Genetics Guided
Dementia Discovery, Eisai, John Reidhaar-Olson, Senior Director,
Pfizer, Oleg Iartchouk, Director, Genomics and Next-Generation
Sequencing, Novartis
culture
1449
Views
08/04/2020 Last update